Among patients with severe isolated aortic stenosis under 65 years of age, the rate of transcatheter aortic valve replacement (TAVR) now nearly matches the rate of surgical aortic valve replacement (SAVR), despite guidelines recommendations to the contrary, as shown by a US national population study.
The researchers note that the 2020 American Heart Association/American College of Cardiology (AHA/ACC) valve guidelines recommend SAVR for patients younger than 65 years of age with severe aortic stenosis, but their study showed “almost equal use between TAVR and SAVR in these younger patients at 2021″ by 48% and 52% respectively.